首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Ipilimumab/nivolumabPapilloedema: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2019年
/ 1768卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-019-66882-0
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:198 / 198
相关论文
共 50 条
[31]
Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly,
2022,
1926
(1)
: 277
-
277
[32]
Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly,
2018,
1722
(1)
: 192
-
192
[33]
Ipilimumab/NivolumabMyelosuppression : case report
Reactions Weekly,
2024,
2017
(1)
: 252
-
252
[34]
Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly,
2022,
1931
(1)
: 319
-
319
[35]
Ipilimumab/nivolumabHepatitis: case report
Reactions Weekly,
2021,
1884
(1)
: 239
-
239
[36]
Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly,
2022,
1901
(1)
: 281
-
281
[37]
Ipilimumab/nivolumabDermatomyositis: case report
Reactions Weekly,
2020,
1819
(1)
: 157
-
157
[38]
Ipilimumab/nivolumabOesophagitis: case report
Reactions Weekly,
2021,
1869
(1)
: 195
-
195
[39]
Ipilimumab/nivolumabColitis: case report
Reactions Weekly,
2019,
1770
(1)
: 225
-
225
[40]
Ipilimumab/nivolumabHepatitis: case report
Reactions Weekly,
2025,
2040
(1)
: 495
-
495
←
1
2
3
4
5
→